Advanced company searchLink opens in new window

ORCHARD THERAPEUTICS (EUROPE) LIMITED

Company number 09759506

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
07 Oct 2024 AA Full accounts made up to 31 December 2023
26 Feb 2024 CS01 Confirmation statement made on 14 February 2024 with updates
26 Feb 2024 SH01 Statement of capital following an allotment of shares on 31 January 2024
  • GBP 875.62446
02 Aug 2023 AA Audit exemption subsidiary accounts made up to 31 December 2022
03 Jul 2023 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/22
03 Jul 2023 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/22
03 Jul 2023 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/22
15 Mar 2023 SH01 Statement of capital following an allotment of shares on 1 February 2023
  • GBP 874.71229
22 Feb 2023 CS01 Confirmation statement made on 14 February 2023 with no updates
03 Oct 2022 AA Full accounts made up to 31 December 2021
29 Aug 2022 AD01 Registered office address changed from , 108 Cannon Street, London, EC4N 6EU to 245 Hammersmith Road 3rd Floor London W6 8PW on 29 August 2022
09 Mar 2022 AP03 Appointment of Mr Christopher Tappan York as a secretary on 28 February 2022
09 Mar 2022 TM01 Termination of appointment of John Edward Ilett as a director on 28 February 2022
09 Mar 2022 TM02 Termination of appointment of John Edward Ilett as a secretary on 28 February 2022
15 Feb 2022 CS01 Confirmation statement made on 14 February 2022 with no updates
08 Oct 2021 AA Full accounts made up to 31 December 2020
05 Mar 2021 CS01 Confirmation statement made on 14 February 2021 with updates
14 Dec 2020 SH01 Statement of capital following an allotment of shares on 10 December 2020
  • GBP 872.99229
01 Oct 2020 AA Full accounts made up to 31 December 2019
27 Jul 2020 SH01 Statement of capital following an allotment of shares on 23 July 2020
  • GBP 872.69229
01 Apr 2020 TM01 Termination of appointment of Mark Rothera as a director on 17 March 2020
25 Feb 2020 CS01 Confirmation statement made on 14 February 2020 with updates
02 Oct 2019 AA Full accounts made up to 31 December 2018
12 Jun 2019 RESOLUTIONS Resolutions
  • RES13 ‐ Facilites agreement 23/05/2019
  • RES01 ‐ Resolution of adoption of Articles of Association
11 Jun 2019 SH08 Change of share class name or designation